Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer.
Saved in:
| Title: | Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer. |
|---|---|
| Authors: | Nassar AH; Division of Medical Oncology, Yale Cancer Center, New Haven, CT, United States.; Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, MA, United States., Bou Farhat E; Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, MA, United States., Abushukair H; Division of Medical Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.; Department of Oncology Science, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Alchoueriy M; Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, MA, United States., Salem S; Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, MA, United States., Machaalani M; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Adib E; Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, MA, United States., Henske EP; Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, MA, United States., Babu P; Division of Medical Oncology, Yale Cancer Center, New Haven, CT, United States., Choueiri TK; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Rakaee M; Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, MA, United States.; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Busund LR; Department of Clinical Pathology, University Hospital of North-Norway, Tromso, Norway., Takabe Y; Division of Medical Oncology, Yale Cancer Center, New Haven, CT, United States., Lau SF; Division of Medical Oncology, Yale Cancer Center, New Haven, CT, United States., Rall K; Division of Medical Oncology, Yale Cancer Center, New Haven, CT, United States., Naqash AR; Division of Medical Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.; Department of Oncology Science, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Jansen C; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States., Wang X; Division of Medical Oncology, Yale Cancer Center, New Haven, CT, United States., Challa P; Division of Medical Oncology, Yale Cancer Center, New Haven, CT, United States., Tarantino P; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Partridge AH; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Tolaney SM; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Kwiatkowski DJ; Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, MA, United States.; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Winer EP; Division of Medical Oncology, Yale Cancer Center, New Haven, CT, United States. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2026 Apr 01; Vol. 118 (4), pp. 669-679. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
